FDAnews
www.fdanews.com/articles/159622-tesaro-begins-clinical-study-of-nausea-drug

Tesaro Begins Clinical Study of Nausea Drug

October 2, 2013
Tesaro has begun a Phase I clinical study of rolapitant IV for chemotherapy-induced nausea.
Pharmaceutical Business Review